Scottish biotech ProStrakan sold for £292m
February 22, 2011Research and Development KHK, Kyowa Hakko Kirin, ProStrakan, Scottish biotech, biotech
Scottish biotech ProStrakan is to be bought by Japanese manufacturer Kyowa Hakko Kirin for £292 million. The companies agreed the …
Pharma must rethink manufacturing, says PwC
February 22, 2011Manufacturing and Production pharma manufacturing, pricewaterhousecoopers, pwC
The pharmaceutical industry needs to undertake a radical overhaul in its approach to manufacturing which at present is “inefficient, under-utilised …
AstraZeneca plans $150m plant in Russia
February 22, 2011Manufacturing and Production, Sales and Marketing AstraZeneca, Russia, emerging pharma markets, pharma manufacturing
AstraZeneca has become the latest drugmaker to announce the construction of a manufacturing facility in Russia to help sidestep possible …
Quality problems lead to short-term layoffs at Baxter Ireland
February 22, 2011Manufacturing and Production Dianeal, Extraneal, Ireland, Nutrineal, baxter, job cuts, manufacturing compliance, peritoneal dialysis
A contaminated production line at a facility in Ireland operated by Baxter Healthcare has resulted in 150 staff being laid …
James Christie joins Oxford BioMedica as manufacturing head
February 22, 2011Manufacturing and Production James Christie, Oxford BioMedica, appointment, manufacturing and production
UK gene therapy company Oxford BioMedica has appointed James Christie as its first head of manufacturing. It following the firm’s …
SHL to speak at Drug Delivery System Development and Lifecycle Management Requirements for Biologic Pharmaceuticals: Trends and Best Practices
February 22, 2011Manufacturing and Production auto injector, autoinjector, drug delivery, shl group
The 2011 DCAT Biologics Forum will focus on trends and best practices for subcutaneous biologic drug delivery systems featuring presentations …
Europe votes in new anti-counterfeit law
February 21, 2011Manufacturing and Production EFPIA, counterfeits, supply chain
The European Parliament has voted in favour of the Falsified Medicines Directive to help stop the flow of counterfeit medicines …
Four steps to turn around a flagging pharma brand
February 21, 2011Sales and Marketing MSI, branding, brands, marketing
The glamorous end of pharma marketing is undoubtedly around the launch of a new product. Everyone is excited and optimistic, …
Idea Pharma boosts UK and US teams
February 21, 2011Sales and Marketing IDEA Pharma, Jeff Frick, Michael Morgan-Curran, appointment, sales and marketing
Idea Pharma has made new appointments to its UK- and US-based teams
Astellas to commercialise new kidney cancer drug in Europe
February 21, 2011Sales and Marketing Astellas, Aveo Pharmaceuticals, Cancer, Kidney cancer, rcc, renal cell carcinoma, tivozanib
Astellas and Aveo Pharmaceuticals are to commercialise Aveo’s investigational kidney cancer drug tivozanib in Europe and the US. Aveo is …
J&J hit by another string of product recalls
February 21, 2011Manufacturing and Production J&J, JJ, Johnson & Johnson, Simponi, golimumab, manufacturing compliance, pharma recalls
There seems to be no end to the quality troubles plaguing Johnson & Johnson, with several more recalls to report, …
Merck KGaA sales soar
February 21, 2011Sales and Marketing 2010 pharma results, Cladribine, Merck KGaA, Merck Serono, Movectro
Merck KGaA’s sales jumped last year by nearly a fifth as recent acquisitions and strong growth on core products set …
Matt de Gruchy to lead Ogilvy Healthworld UK
February 18, 2011Medical Communications Matt de Gruchy, Ogilvy Healthworld UK, appointment, medical communications
Comms agency Ogilvy Healthworld UK has appointed Matt de Gruchy as chief executive. Matt is a 14 year veteran of …
Digital Pharma: Merck Serono sets up MS social network
February 18, 2011Medical Communications Digital Pharma blog, MS, Merck Serono, Movectro, Rebif, multiple sclerosis, social networking
Merck Serono has set up an international social network for multiple sclerosis patients, saying today’s pharma companies should go beyond …
Merck Serono halts Movectro European licence application
February 18, 2011Medical Communications, Sales and Marketing Cladribine, MS, Merck KGaA, Merck Serono, Movectro, fingolimod, gilenya, multiple sclerosis
Merck Serono has withdrawn its European licence application for multiple sclerosis drug Movectro. Movectro (cladribine) is a new oral treatment …
Value-based pricing will not harm industry, says NICE chief
February 18, 2011Sales and Marketing Health Select Committee, Health and Social Care Bill, NHS reform, NICE, Sir Andrew Dillon, value-based pricing
NICE’s chief executive Sir Andrew Dillon says he believes plans to introduce value-based pricing of medicines will not have a …
AZ accepts $92.5m to settle respiratory dispute
February 18, 2011Sales and Marketing AZ, AstraZeneca, MedImmune, PDL BioPharma, Synagis, patent dispute, respiratory
AstraZeneca’s MedImmune subsidiary is to receive $92.5 million as part of a legal settlement involving its respiratory drug Synagis. PDL …
Trial failures threaten UK biotech
February 18, 2011Research and Development AML, AS1411, AS1413, Antisoma, Juvista, Renovo, UK biotech, acute myeloid leukaemia, anti-scarring, biotech
A number of late stage failures from British biotech firms have left a looming question mark over the future of …
Bennett appointed chairman of Monitor
February 18, 2011Sales and Marketing Monitor, NHS
Monitor, the body which will take on a powerful new role in regulating competition in the NHS, has a new …
Vidaza patient access scheme sways NICE
February 17, 2011Sales and Marketing Celgene, NICE, Vidaza
Celgene’s Vidaza has been recommended by NICE in final draft guidance issued today. Vidaza (azacitidine) is recommended as a treatment …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
